PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare Conference
INCLINE VILLAGE, Nev., Nov. 8, 2011/PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Lazard Capital Markets 8th Annual Healthcare Conference next week in New York City. The presentation will begin at 10 a.m. EST on Tuesday, November 15, 2011.
(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)
To access the live and subsequently archived webcasts of the presentations, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
